Top Medicine has made its own formula for success by focusing on its pharmaceutical intermediates sector which is the strongest among main business activities. D-Dihydrophenylglycine Sodium Dane Salt, side chain for Cefradine, enjoys the largest capacity in China, and good consistency in quality and service with the yearly capacity up to 1,000 tons and a 40% market share in China. SIN-methoxyimno-furanyl-acetic acid ammonium salt (SMIA) is a side chain of Cefuroxime. (S)-pyrrolidine-2-carboxamide and 1-amino-3-hydroxyadamantane, key intermediates for Vildagliptin, are leading spikes and new economic growth potentials. Calcium Polycarbophil, an API for chronic constipation and watery diarrhea, enjoys substantial market shares in USA, EU countries, Japan and South Korea. Some new applications and leading spikes are under development now. [ Click for details ]